AR060555A1 - Solucion de aminoacidos pediatrica para nutricion parenteral - Google Patents

Solucion de aminoacidos pediatrica para nutricion parenteral

Info

Publication number
AR060555A1
AR060555A1 ARP070101703A ARP070101703A AR060555A1 AR 060555 A1 AR060555 A1 AR 060555A1 AR P070101703 A ARP070101703 A AR P070101703A AR P070101703 A ARP070101703 A AR P070101703A AR 060555 A1 AR060555 A1 AR 060555A1
Authority
AR
Argentina
Prior art keywords
parenteral nutrition
amino acids
acids solution
pediatric
pediatric amino
Prior art date
Application number
ARP070101703A
Other languages
English (en)
Spanish (es)
Inventor
Ortrud Brand
Thorsten Erbe
Georg Achleitner
Norbert Feichtinger
Original Assignee
Fresenius Kabi De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38006821&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR060555(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fresenius Kabi De Gmbh filed Critical Fresenius Kabi De Gmbh
Publication of AR060555A1 publication Critical patent/AR060555A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP070101703A 2006-04-20 2007-04-20 Solucion de aminoacidos pediatrica para nutricion parenteral AR060555A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006018293A DE102006018293A1 (de) 2006-04-20 2006-04-20 Pädiatrische Aminosäurelösung zur parenteralen Ernäherung

Publications (1)

Publication Number Publication Date
AR060555A1 true AR060555A1 (es) 2008-06-25

Family

ID=38006821

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070101703A AR060555A1 (es) 2006-04-20 2007-04-20 Solucion de aminoacidos pediatrica para nutricion parenteral

Country Status (15)

Country Link
US (1) US8377876B2 (enExample)
EP (1) EP2007348B1 (enExample)
JP (1) JP2009534323A (enExample)
KR (1) KR20090010050A (enExample)
CN (2) CN101420933A (enExample)
AR (1) AR060555A1 (enExample)
AU (1) AU2007241469B2 (enExample)
BR (1) BRPI0710298A2 (enExample)
CA (1) CA2647087A1 (enExample)
DE (1) DE102006018293A1 (enExample)
EA (1) EA015709B1 (enExample)
MX (1) MX2008013540A (enExample)
TW (1) TWI429405B (enExample)
WO (1) WO2007121807A1 (enExample)
ZA (1) ZA200807860B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102065698A (zh) 2008-06-19 2011-05-18 荷兰联合利华有限公司 具有铁和锌的含脂肪食用乳液
AU2009268742C1 (en) 2008-07-07 2013-11-28 Pentec Health, Inc. Nutritive compositions and methods of using same
JP2011121889A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
CA2786375A1 (en) * 2010-01-04 2011-07-07 Pentec Health, Inc. Nutritive compositions and methods of using same
JP2011144116A (ja) * 2010-01-12 2011-07-28 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用添加剤
US20110208153A1 (en) * 2010-02-24 2011-08-25 John Alvey Formulations and methods for nutrient delivery
JP6000253B2 (ja) 2010-09-24 2016-09-28 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 胃腸機能を改善するための材料および方法
EP2489408A1 (de) * 2011-01-13 2012-08-22 Michael Tchirikov Aminosäurezusammensetzung und deren Verwendung zur Behandlung von fetaler Wachstumsrestriktion (IUGR) und zur parenteralen Ernährung von extrem Frühgeborenen
CN104039174B (zh) * 2012-01-09 2016-11-16 N·V·努特里奇亚 用于早产婴儿的富含谷氨酰胺的营养组合物
MX368543B (es) * 2012-02-08 2019-10-07 Univ Florida Composiciones para tratar diarrea inducida por rotavirus.
BR112015016465B1 (pt) * 2013-01-09 2020-11-10 N.V. Nutricia uso de glutamina ou de uma composição; método não-medicinal para melhora posterior da função cognitiva em um bebê muito prematuro nascido pequeno para a idade gestacional; e método não-medicinal para melhora posterior do q.i em um bebê muito prematuro nascido pequeno para a idade gestacional
WO2014164736A1 (en) 2013-03-11 2014-10-09 University Of Florida Research Foundation, Incorporated Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications
CN103404934B (zh) * 2013-08-24 2015-07-01 江苏阜丰生物科技有限公司 一种含谷氨酰胺的解酒固体饮料及其制备方法
WO2015178762A1 (en) * 2014-05-19 2015-11-26 N.V. Nutricia Enteral formulations for preterm infants comprising optimised phenylalanine intake levels
WO2015178761A1 (en) 2014-05-19 2015-11-26 N.V. Nutricia Formulas comprising optimised amino acid profiles
JOP20190276A1 (ar) * 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
CN107898808B (zh) * 2017-10-31 2021-04-27 华仁药业股份有限公司 小儿用静脉营养制剂
RU2699222C1 (ru) * 2019-04-29 2019-09-04 Алексей Владимирович Воронов Солевой электролитный раствор для проведения энтеральных инфузий
EP4125436A4 (en) * 2020-04-01 2024-05-15 The E. Wolfson Medical Center ULCEROUS COLITIS DIET, RELATED FORMULAS, PRODUCTS AND METHODS
US20220378077A1 (en) * 2021-05-25 2022-12-01 Baxter International Inc. Ready-To-Use Parenteral Nutrition Formulation
IT202200015885A1 (it) * 2022-07-27 2024-01-27 St G Gaslini Sacca standardizzata per alimentazione di nati pretermine e dispositivo di alimentazione di nati pretermine

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3206784C2 (de) * 1982-02-25 1985-05-09 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Glutaminhaltige Zubereitungen für orale oder intravenöse Applikation
FR2556594B1 (fr) * 1983-12-20 1988-09-09 Synthelabo Solutions d'acides amines
US5684045A (en) * 1985-09-12 1997-11-04 Brigham And Women's Hospital Method of treating pancreatic atrophy
JPH0710770A (ja) * 1990-03-14 1995-01-13 Otsuka Pharmaceut Factory Inc アミノ酸輸液
US5206220A (en) * 1990-04-23 1993-04-27 Research Corporation Technologies, Inc. Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition
JPH05507472A (ja) * 1990-04-23 1993-10-28 リサーチ・コーポレイション・テクノロジーズ・インコーポレイテッド 経静脈栄養法のためのチロシン、システイン、グルタミンの可溶性で安定な供給源
SE9003844L (sv) * 1990-12-03 1992-06-04 Kabi Pharmacia Ab Naeringstillsats
JPH06227974A (ja) * 1993-01-29 1994-08-16 Kyowa Hakko Kogyo Co Ltd 栄養組成物
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
FR2711529B1 (fr) * 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
US5561111A (en) * 1994-12-23 1996-10-01 The University Of Virginia Patent Foundation Stable glutamine derivatives for oral and intravenous rehydration and nutrition therapy
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
ID27818A (id) * 1998-03-31 2001-04-26 Nestle Sa Metode untuk menyediakan glutamin
US7148199B2 (en) * 2003-09-26 2006-12-12 University Of Florida Research Foundation, Inc. Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation

Also Published As

Publication number Publication date
EA015709B1 (ru) 2011-10-31
BRPI0710298A2 (pt) 2011-08-09
US20090203626A1 (en) 2009-08-13
EA200870451A1 (ru) 2009-04-28
WO2007121807A1 (de) 2007-11-01
JP2009534323A (ja) 2009-09-24
US8377876B2 (en) 2013-02-19
MX2008013540A (es) 2008-10-31
CN104524542A (zh) 2015-04-22
CN101420933A (zh) 2009-04-29
ZA200807860B (en) 2009-08-26
EP2007348B1 (de) 2014-12-10
KR20090010050A (ko) 2009-01-28
TWI429405B (zh) 2014-03-11
AU2007241469A1 (en) 2007-11-01
EP2007348A1 (de) 2008-12-31
CA2647087A1 (en) 2007-11-01
AU2007241469B2 (en) 2012-09-20
TW200740380A (en) 2007-11-01
DE102006018293A1 (de) 2007-10-25

Similar Documents

Publication Publication Date Title
AR060555A1 (es) Solucion de aminoacidos pediatrica para nutricion parenteral
ECSP088758A (es) Métodos para reducir la aglomeración de proteína
CY1117328T1 (el) Διαδικασια για την παρασκευη πολυσιαλικου οξεος υψηλης καθαρiοτητας
CY1113819T1 (el) Σκευασματα για τη θεραπευτικη αντιμετωπιση του καρκινου
DE602006015292D1 (de) Zuführung von molekülen an eine lipiddoppelschicht
CL2012000063A1 (es) Polipéptido factor ix (fix) o un fragmento del mismo porque comprende la modificación de un aminoácido; vector; célula; método para expresar el polipéptido fix; composición farmacéutica; uso de la composición para tratar enfermedades trombóticas, hemorrágicas y coagulación intravascular diseminada (cid) (div. sol. 1796-07).
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
CO6180433A2 (es) Moleculas de enlace de lingo y uso farmaceutico de las mismas
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
CL2007003077A1 (es) Procedimiento para separar componentes disueltos de una solucion que comprende introducir una primera solucion en un estanque solar, introducir parte de dicha solucion en una unidad de osmosis y contactar con una solucion con menor concentracion de s
MY160552A (en) Low protein infant formula with increased essential amino acids
DK1957061T3 (da) Kombination omfattende mindst én aminosyre og en PKR-inhibitor til anvendelse i behandlingen af muskelsvind
WO2012095868A3 (en) Bridge button for ligament reconstruction
EE05536B1 (et) N-karbamoüülmetüül-4-(R)-fenüül-2-pürrolidinoon, selle valmistamise meetod ja farmatseutiline kasutamine
CY1118302T1 (el) Λωριδα χαρτιου για τον καθορισμο των ελαχιστων ανασταλτικων συγκεντρωσεων αντιβιοτικων
BR112013022941A2 (pt) método para produzir glicopeptídeo tendo sialylaçúcar cadeia, derivado de aminoácido sialyl sugar chain-added para ser usado na mesmma e glicopeptídeos
BRPI0720230A2 (pt) Uso de uma formulação nutricional oralmente administrável, formulação nutricional, método para tratar um distúrbio desenvolvimental penetrante, e, composição
EA200900780A1 (ru) Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства
MX2011011351A (es) Agentes de imagenologia molecular etiquetados, metodos para hacerlos y metodos de uso.
DK1853248T3 (da) Anvendelse af salte, additionsforbindelser og kompleksforbindelser af quanidinoeddikesyre
CL2012003119A1 (es) Composicion farmaceutica para inyeccion que compende una solucion acuosa de ibuprofeno y trometamol, en que la concentracion de ibuprofeno esta entre 2 y 6 mg/ml, la concentracion de trometamol esta entre 1.8 y 5.8 mg/ml, y el ph esta entre 7,0 y 9,5; y su uso para el tratamiento del dolor, la inflamacion o la fiebre.
AR054157A1 (es) Medio de cultivo libre de suero para la produccion de las gonadotropinas recombinantes
BRPI0822570A2 (pt) Processo, equipamento portátil e dispositivo para a determinação fotométrica in vitro da concentração de hemoglobina em uma amostra de sangue diluída em uma só etapa
EA200801875A1 (ru) Антагонист cd 80
ES2543724T3 (es) Preparación farmacéutica para el tratamiento de patologías depresivas, que comprende una proteína con alta proporción triptófano/LNAA (Large Neutral Amino Acids, aminoácidos neutros grandes)

Legal Events

Date Code Title Description
FB Suspension of granting procedure